¤@¡B¤p²ÓMªÍÀù¬O§_n¶i¦æ¤ÆªÍÀùªº¯f²zÃþ«¬¬O«Ü¦hªº¡A±`¨£ªº¬OÅìÀù¡A¸¢Àù©M¤p²ÓMÀùµ¥¡A¨ä¤¤¤p²ÓMªÍÀù´c©Ê«×°ª¡A¹w«á¸û®tªº¡A¤Î®É³W½dªºªvÀø¬OÃöÁä¡A¤£¤Î®ÉªvÀøªº¸Ü¡A®e©ö¾ÉP°©Âಾ¡A©Î¬O¸£Âಾªº¡A¦ý¹ï©ñ¤ÆÀø¬O¤ñ¸û±Ó·Pªº¡A»Ýn¤Î®Éªº©ñ¤ÆÀøªvÀø¡AªvÀøªº¥Øªº¥u¯à¬O©µ½w¥Í©R¡A¤£¯à®Úªvªº¡C
¤TÅé¤ûÃ@
¤TÅé¤ûÃ@®ÄªG
¤TÅé¤ûÃ@¯u°°
¤TÅé¤ûÃ@ªvÀø¦¬ª
¤TÅé¤ûÃ@·s¤@¥N
¤TÅé¤ûÃ@¤fªA³t®Ä
¤TÅé¤ûÃ@®ÚªvºÃÃøÂø¯g
¯«¯h¥F¤O
¬È´HªÏ§N
¤TÅé¤ûÃ@®MÀ\
¤TÅé¤ûÃ@¯u³f
¤p²ÓMªÍÀùªºªvÀø¥H¤ÆÀø¬°¥D¡A¥i¥HÁp¦X©Î§Ç³e¥H©ñÀø¡A¹ï©ó¤£¨ì5%ªº¶È©óªÍ¹ê½è¤ºªº¦´Á±wªÌ¦Ò¼{¤â³NªvÀø¡C §½´ÁSCLC¥H¦P¨B©ñ¤ÆÀø©Î¤ÆÀø¡B©ñÀø§Ç³eªvÀø¬°¥D¡A¦P¨B©ñ¤ÆÀøÀu©ó§Ç³eªvÀø¡A¦P¨B©ñ¤ÆÀøÀ³¾¨¦¡A¨ÃÀ³µ¹¤©¹w¨¾©Ê¥þ¸£©ñÀø¡A¹w¨¾©Ê¥þ¸£©ñÀø¹ï¥Í¦sªº¯q³BÅãµÛ¡C ¼sªx´ÁSCLC¥H¤ÆÀø¬°¥D¡A¾Ü´Á¦æ§½³¡©ÎÂಾ¨_ªvÀø¡C
¤p²ÓMªÍÀùªºªvÀø¤ô·Ç¦bªñ30¦h¦~¨Ó³B©ó¥»O´Á¡A¶È¦b¦P¨B©ñ¤ÆÀø©M¥þ¸£¹w¨¾©Ê©ñÀø¤è±¨ú±o¤F¤@¨Ç¶i®i¡A¥Ø«e¤p²ÓMªÍÀùªìªv®Éªº¤À´Á¡B³W½dªºªvÀø¨ÌµM¬OÀò±oº¡·NÀø®ÄªºÃöÁä¡C
¤G¡B¤p²ÓMªÍÀù¬O¦]¬°¤°»òì¦]¤Þ°_
¤TÅé¤ûÃ@©xºô
¤TÅé¤ûÃ@µû»ù
¤TÅé¤ûÃ@ÁʶR
¤TÅé¤ûÃ@ªvÀø¶§·õ
¤TÅé¤ûÃ@¬õ¸Ëª©
¤TÅé¤ûÃ@«k°Ê¤O
¶§·õ
¦¬ª
¤TÅé¤ûÃ@Àø®Ä
ªº
¯f²z²Õ´¾Ç¤WSCLC¥i¤À¬°¡G¤p²ÓMªÍÀù¡]¥]¬A¥H©¹ªº¿P³Á²ÓMÀù¡^¡B²V¦X©ÊÀù¡]§Y¤p²ÓMÀù»PÅì©Î¸¢Àùªº²V¦X«¬¡^¡C
¥Ø«eSCLCªvÀø»â°ì³Ì±`¥Îªº¤À´Á¨t²Î¬°¬ü°ê°h¥îx¤HÂå°|ªÍÀù¬ã¨s¤p²Õ¨î©wªºSCLC¤À´Á¨t²Î¡G¦pªG¸~½F§½©ó¤@°¼¯ÝµÄ¡]¥]¬A¨ä¤Þ¬yªº°Ï°ì²O¤Úµ²¡A¦p¦P°¼ªÍªù¡BÁa¹j©ÎÂê°©¤W²O¤Úµ²¡^¥B¯à³Q¯Ç¤J¤@Ó©ñ®gªvÀø³¥§Y¬°§½´Á¡]Limited Disease¡ALD¡^¡A¦pªG¸~½F¶W¥X§½´Á½d³ò§Y¬°¼sªx´Á¡]Extensive Disease¡AED¡^¡A¨ä¤¤«eªÌ¬ù¦û1/3¡A«áªÌ¦û2/3¡C ³oºØ¤À´Á¤èªk²³æ¡B©ö¦æ¡A»PªvÀøÀø®Ä¤Î¹w«á¬ÛÃö¡C TNM¤À´Á¥Ø«e¤]¥Î©óSCLCªº¤À´Á¡C
¤TÅé¤ûÃ@ª½À穱
¤TÅé¤ûÃ@µû½×
¤TÅé¤ûÃ@¦¨¤À
¤TÅé¤ûÃ@¸g¨åª©
¤ûÄ_½¦Ån
¤TÅé¤ûÃ@±`¨£°ÝÃD
¤TÅé¤ûÃ@®×¨Ò
¯«¯h¥F¤O
¬È´HªÏ§N
¤TÅé¤ûÃ@¹ê©ç
§l·Ï¬OªÍÀùªº¥Dn¦MÀI¦]¯À¡ASCLC»P§l·ÏÃö«Y±K¤Á¡C ®Ú¾Ú¹ï1970-1999¦~¥@¬É½d³ò¤º§l·Ï»PªÍÀùªº¶×Á`¤ÀªR¡AªÍÀù»P§l·Ï±j«×¡]§l·Ï¶q¡^©M«ùÄò®É¶¡§e¥¿¬ÛÃö¡A»PSCLCªºÃö«Y³Ì¬°©úÅã¡C
¹L¥h´X¤Q¦~¤¤SCLCµo¥Íªº¤À¤l¾÷¨îªº¬ã¨s¸û¦h¡A´£¥ÜSCLCªºµo¥Í¥i¯à¥]§t¦hºØ°ò¦]ªº°Ñ»P¡C ¦³¬ã¨s»{¬°§íÀù°ò¦]p53¡BRB°ò¦]¡]µø¯«¸g¥À²ÓM½F°ò¦]¡^¡AÀù°ò¦]Bcl-2°ò¦]¡BMyc°ò¦]¡A PI3K/AKT/mTOR«H¸¹Âà¾É³~®|µ¥§¡»PSCLCªºµo¯f¦³¤@©wÃö«Y¡C
¦wÀ²¤TÅéÂåÃÄ«O°·ª½À穱
¤TÅé¤ûÃ@¦Yªk
¤TÅé¤ûÃ@°Æ§@¥Î
¤TÅé¤ûÃ@Ÿ˪©
¤TÅé¤ûÃ@¹ê©ç
¤TÅé¤ûÃ@ÀuÂI
µÇÁ«
§¿ÀW
¤TÅé¤ûÃ@¬ãµo
¤T¡B¤p²ÓMªÍÀù¦³þ¨ÇÁ{§Éªí
§l·Ï¤H¸s¬°°ªµo¤H¸s¡A¤p²ÓMªÍÀù±wªÌ¤¤90%¥H¤Wªº¤H¦³§l·Ï¥v¡C µo¯f¦~ÄÖ35-68·³¡A¥§¡µo¯f¦~ÄÖ60·³¡A¨k©Ê¦h©ó¤k©Ê¡C
¤p²ÓMªÍÀù¦´Á¥iµLÄpª¬¡A¶EÂ_®É³Ì±`¨£ªºÄpª¬¬°¥F¤O¡]80%¡^¡B«y¹Â¡]70%¡^¡B®ðµu¡]60%¡^¡BÅ髤U°¡]55%¡^¡B¯kµh¡]40-50%¡^¡B«£¦å¡]25%¡^¡C